ES2010761A6 - Un procedimiento para obtener una linea celular hibrida productora de un anticuerpo monoclonal especifico de sitio determinante comun de neutrofilos y eosinofilos. - Google Patents

Un procedimiento para obtener una linea celular hibrida productora de un anticuerpo monoclonal especifico de sitio determinante comun de neutrofilos y eosinofilos.

Info

Publication number
ES2010761A6
ES2010761A6 ES8802048A ES8802048A ES2010761A6 ES 2010761 A6 ES2010761 A6 ES 2010761A6 ES 8802048 A ES8802048 A ES 8802048A ES 8802048 A ES8802048 A ES 8802048A ES 2010761 A6 ES2010761 A6 ES 2010761A6
Authority
ES
Spain
Prior art keywords
neutrophils
eosinophils
monoclonal antibody
antibody specific
determinant site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8802048A
Other languages
English (en)
Inventor
Kenneth H Kortright
David E Hofheinz
Gary P Toedter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coulter Corp
Original Assignee
Coulter Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coulter Corp filed Critical Coulter Corp
Publication of ES2010761A6 publication Critical patent/ES2010761A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN PROCEDIMIENTO PARA OBTENER UNA LINEA CELULAR HIBRIDA PRODUCTORA DE UN ANTICUERPO MONOCLONAL ESPECIFOCO DE SITIO DETERMINANTE COMUN DE NEUTROFILOS Y EOSINOFILOS. UN PROCEDIMIENTO PARA LA OBTENCION DE UNA LINEA DE CELULAS HIBRIDAS CAPAZ DE PRODUCIR ANTICUERPOS MONOCLONALES UNICAMENTE ESPECIFICOS DE NEUTROFILOS Y EOSINOFILOS HUMANOS Y QUE NO PRESENTAN NINGUNA ESPECIFICIDAD POR LOS LINFOCITOS, BASOFILOS Y MONOCITOS. ADEMAS, NO EXISTE REACTIVIDAD CON LAS CELULAS DE LA LEUCEMIA AGUDA. UNO DE LOS COPARTICIPES EN LA FUSION DEL HIBRIDOMA DE UNAS CELULAS DE BAZO DE RATON SE OBTIENE MEDIANTE EL USO DE GRANULOCITOS HUMANOS COMO AGENTE INMUNIZANTE. EL ANTICUERPO MONOCLONAL PUEDE SER UTILIZADO ADEMAS EN UN METODO PARA ENUMERAR Y AISLAR NEUTROFILOS EN SANGRE PERIFERICA NORMAL Y POSIBLEMENTE EN LA SANGRE DE PACIENTE DE LEUCEMIA AGUDA.
ES8802048A 1987-06-30 1988-06-29 Un procedimiento para obtener una linea celular hibrida productora de un anticuerpo monoclonal especifico de sitio determinante comun de neutrofilos y eosinofilos. Expired ES2010761A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6861887A 1987-06-30 1987-06-30
US07/142,936 US4865971A (en) 1987-06-30 1988-01-12 Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils

Publications (1)

Publication Number Publication Date
ES2010761A6 true ES2010761A6 (es) 1989-12-01

Family

ID=26749170

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8802048A Expired ES2010761A6 (es) 1987-06-30 1988-06-29 Un procedimiento para obtener una linea celular hibrida productora de un anticuerpo monoclonal especifico de sitio determinante comun de neutrofilos y eosinofilos.

Country Status (12)

Country Link
US (1) US4865971A (es)
EP (1) EP0371026B1 (es)
JP (1) JP2579354B2 (es)
KR (1) KR970001812B1 (es)
CN (1) CN1031759C (es)
AR (1) AR241656A1 (es)
CA (1) CA1297817C (es)
DE (1) DE3888971T2 (es)
ES (1) ES2010761A6 (es)
IE (1) IE61554B1 (es)
IL (1) IL86678A0 (es)
WO (1) WO1989000169A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179019A (en) * 1988-03-31 1993-01-12 Biomedical Systems Limited Therapeutic murine monoclonal antibody
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US5217870A (en) * 1989-04-28 1993-06-08 Biogen, Inc. Monoclonal antibodies against CDX
US5340719A (en) * 1990-11-23 1994-08-23 Corporation Coulter Method and apparatus for optically screening microscopic cells
US5348859A (en) * 1990-11-23 1994-09-20 Coulter Corporation Method and apparatus for obtaining an absolute white blood cell subset count and white blood cell multipart differential

Also Published As

Publication number Publication date
IE881273L (en) 1988-12-30
KR970001812B1 (ko) 1997-02-15
JPH03500841A (ja) 1991-02-28
EP0371026B1 (en) 1994-04-06
US4865971A (en) 1989-09-12
CN1030610A (zh) 1989-01-25
DE3888971D1 (de) 1994-05-11
KR890701633A (ko) 1989-12-21
EP0371026A1 (en) 1990-06-06
CN1031759C (zh) 1996-05-08
IL86678A0 (en) 1988-11-30
EP0371026A4 (en) 1990-10-10
AR241656A1 (es) 1992-10-30
JP2579354B2 (ja) 1997-02-05
IE61554B1 (en) 1994-11-16
DE3888971T2 (de) 1994-08-04
WO1989000169A1 (en) 1989-01-12
CA1297817C (en) 1992-03-24

Similar Documents

Publication Publication Date Title
Swain et al. Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays.
Lockshin et al. Cell‐mediated immunity in rheumatic diseases
IL86676A0 (en) Cell line and monoclonal antibodies
Ehrlich et al. Cooperative immunoassays: ultrasensitive assays with mixed monoclonal antibodies
ATE70309T1 (de) Menschliche monoklonale antikoerper gegen bakterielle toxine.
AU544792B2 (en) Monoclonal antibodies to human helper t cells
PH16642A (en) Complement-fixing monoclonal antibody to human t cells,and methods of preparing same
KR880006357A (ko) 인터류킨-i에 대한 항체
IL61863A (en) Monoclonal antibody to a human monocyte antigen,its production and diagnostic and pharmaceutical compositions contaiing it
IT8820741A0 (it) Anticorpo monoclonale specifico per una sequenza di fibronettina espressa in cellule trasformate ibridoma secernente tale anticorpo e impiego dell'anticorpo monoclonale per la diagnosi di tumori.
ATE88751T1 (de) Monoklonaler antikoerper spezifisch gegen neutrophilen.
IT1257893B (it) Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.
ES2010761A6 (es) Un procedimiento para obtener una linea celular hibrida productora de un anticuerpo monoclonal especifico de sitio determinante comun de neutrofilos y eosinofilos.
EP0178891A3 (en) Human-human hybrid cell lines that produce antibodies against antigenic determinants on cancer cells
EP0204522A3 (en) Monoclonal antibody panel for histocompatibility typing
AU5575990A (en) Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
Padula et al. Maintenance of antigen specificity by human interleukin-2-dependent T cell lines. Use of antigen-presenting cells and OKT3 antibody in the absence of antigen.
KR850006705A (ko) 항파상풍항체 생산 인체-인체 하이브리도마의 제조방법
Daniels,* et al. A monoclonal antibody related to the human blood group Gerbich
EP0205352A3 (en) Monoclonal anti-human igg4 antibodies, their production and use
Brettle HIV: The Edinburgh epidemic
EP0311438A3 (en) Monoclonal antibody to activated lymphocytes and cancer cells
Romain et al. [15] Use of anti-fab columns for the isolation of human lymphocyte populations
EP0265156A3 (en) Monoclonal antibodies
ES2008956A6 (es) Un procedimiebto para obtener una linea de celulas hibridas capaces deproducir anticuerpos monoclonales singularmente especificos de los neutrofilos humanos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000503